Market Closed -
Other stock markets
|
Pre-market 07:29:38 am | |||
26.27 USD | -0.19% | 26.3 | +0.11% |
12:11pm | Scholz promises support for pharma sector in Germany as Merck invests | RE |
Apr. 24 | Pfizer Keeps Q2 Dividend at $0.42 a Share, Payable June 14 to Holders of Record May 10 | MT |
Financials (USD)
Sales 2024 * | 59.96B | Sales 2025 * | 62.57B | Capitalization | 149B |
---|---|---|---|---|---|
Net income 2024 * | 6.75B | Net income 2025 * | 9.29B | EV / Sales 2024 * | 3.27 x |
Net Debt 2024 * | 47.04B | Net Debt 2025 * | 41.91B | EV / Sales 2025 * | 3.05 x |
P/E ratio 2024 * |
19.3
x | P/E ratio 2025 * |
14
x | Employees | 88,000 |
Yield 2024 * |
6.46% | Yield 2025 * |
6.62% | Free-Float | 59.09% |
Latest transcript on Pfizer, Inc.
1 day | +0.11% | ||
1 week | +3.34% | ||
Current month | -5.33% | ||
1 month | -3.98% | ||
3 months | -7.27% | ||
6 months | -13.67% | ||
Current year | -8.75% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 92-12-31 |
David Denton
DFI | Director of Finance/CFO | 59 | 22-05-01 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-03-31 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 17-02-22 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 13-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.74% | 215 M€ | +11.68% | - | |
9.37% | 18 M€ | +3.04% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 26.27 | -0.19% | 24,547,780 |
24-04-23 | 26.32 | +0.23% | 24,297,821 |
24-04-22 | 26.26 | +1.00% | 35,678,657 |
24-04-19 | 26 | +2.40% | 38,372,801 |
24-04-18 | 25.39 | -0.12% | 35,788,351 |
Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.75% | 149B | |
+25.61% | 660B | |
+22.62% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.68% | 219B | |
-9.69% | 196B | |
+6.47% | 199B | |
-5.21% | 146B |
- Stock Market
- Equities
- PFE Stock